REBLOZYL® (luspatercept-aamt) is a prescription medicine used to treat anemia (low red blood cells) without previous erythropoiesis stimulating agent use (ESA-naïve) in adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS) who may require regular red blood cell (RBC) transfusions.
It is not known if REBLOZYL is safe or effective in children under 18 years of age.
This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.
REBLOZYL for anemia in adults with MDS
MDS & Anemia
About REBLOZYL
Starting & Staying
Caregivers
REBLOZYL for anemia in adults with BT
BT & Anemia
About REBLOZYL
Starting & Staying
Resources
FAQ